Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency. - Wikidata - awgldk - TriplyDB

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

http://www.wikidata.org/entity/Q34936507

about

"Inflamm-aging" influences immune cell survival factors in human bone marrow.Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity.High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner Novel immunotherapies for the treatment of melanoma.Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.Therapeutic Cancer Vaccines.Caudatin induces caspase-dependent apoptosis in human glioma cells with involvement of mitochondrial dysfunction and reactive oxygen species generation.CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression.Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4+ T cells combined with agonist α-GITR mAb promotes durable CD8+ T-cell-dependent antitumor immunity.Tumor-derived high-mobility group box 1 and thymic stromal lymphopoietin are involved in modulating dendritic cells to activate T regulatory cells in a mouse model.

P2860

Q33697840-0CC14EAF-9AD6-41DB-9CBE-FF94FE84A9E3 Q35691240-6AEF8277-CA59-4650-930B-2D631D0A386F Q36517092-12135D45-F72A-4E19-AF50-A5B079C38414 Q38824190-6C0AB898-AB3B-44F5-ACFE-0C7B6101D2D8 Q39015531-FD70FFF3-1799-4D9D-96A6-D7CDD6B3498C Q40728648-2234933D-5A9E-4D42-8858-CF5308D4607C Q46547610-A705D70D-93F4-46A6-9D86-7FA4FF4FF0C2 Q47677316-82FCEB62-BFB8-41DD-AFDC-EBC346C7A71E Q48170351-687D029F-D3CE-47E7-9EBD-53150CF707B8 Q50109080-5A3176AA-92A2-48E5-9612-049554D09ABA

P2860

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

http://www.wikidata.org/entity/Q34936507

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

@ast

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

@en

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

@nl

type

label

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

@ast

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

@en

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

@nl

prefLabel

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

@ast

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

@en

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

@nl

P1433

Q34936507-CEF61F5E-4A2E-415F-9866-D7A3AE134B27

P1476

Q34936507-92A2239F-9DE2-4E58-9458-2C7219DB13A8

P2093

Q34936507-0A5A9167-4FD2-4B44-BC07-5E701507B13B

Q34936507-1E1E045A-4C8D-498B-8CAC-FF1CAEC0613B

Q34936507-263E0ECA-71D1-48B0-A1D2-28060CE3BE98

Q34936507-293F3094-74A6-43CC-8DDE-570427320B99

Q34936507-79366CD0-1F50-4AC7-8630-946E183FFCE9

Q34936507-7BBDFBCC-26E1-4910-A3C6-0985597ECBB5

Q34936507-8D5FA83C-A0C4-45E5-BD43-A60F9672CEB9

Q34936507-A5B21378-9EAF-4C3C-A328-2FE5670134F7

Q34936507-C4F4957A-2DFA-487D-A8A6-371F1BC8F2EA

Q34936507-DEDEFD99-6F05-44BC-8FEB-324527755DEC

P2860

Q34936507-05C7E02A-D797-4158-BE9C-0E2ACE9E9930

Q34936507-0FE30882-B59F-4046-A297-03B45EFAEEDE

Q34936507-11A01AB2-7189-4A60-B770-89CD35567C22

Q34936507-14414592-2C41-43C4-84B7-C9E6C90F5816

Q34936507-1EE58BEB-3C3C-47D8-A9B2-A05FDD5199E5

Q34936507-20EB541E-965A-4600-8C41-7AE5D964715C

Q34936507-21F4401A-E3DC-4AD9-9966-1AB589ABB126

Q34936507-24AF93E7-5495-4DDA-ABA3-F1CD404485F9

Q34936507-38707019-1647-4161-8DAE-884577D0BF75

Q34936507-3915FB2A-B67F-4E74-B761-C33F5350D647

P304

Q34936507-05F7F410-C2C8-452D-BC4F-3EB11DEB2877

P31

Q34936507-C967B49F-F7E6-4955-8554-47A95025D1E4

P356

Q34936507-897EF6FF-3886-4FF2-A454-7E2C191B2D1A

P433

Q34936507-E5D1FAAC-52FA-43E2-B249-85E5774DD98B

P478

Q34936507-9A9A8130-7FCA-4675-A418-BBCD79528509

P577

Q34936507-AE96EFBA-162E-4FE3-A81F-D042DD6ABEAD

P5875

Q34936507-9D0E4A49-E7C4-46F7-81D8-E495BC73DA92

P698

Q34936507-30AB3E53-FF63-4458-BDA1-20978AB43EE4

P932

Q34936507-32B0804A-37AE-427F-97DE-522F2C8E55F9

P356

21624011.2014.959321

P1433

P1476

Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.

@en

P2093

Jiying Zhang

http://www.w3.org/2001/XMLSchema#string

Louis D Falo

http://www.w3.org/2001/XMLSchema#string

Marcus W Bosenberg

http://www.w3.org/2001/XMLSchema#string

Meili Zhang

http://www.w3.org/2001/XMLSchema#string

Ross M Kedl

http://www.w3.org/2001/XMLSchema#string

Shenghe Tian

http://www.w3.org/2001/XMLSchema#string

Thomas A Waldmann

http://www.w3.org/2001/XMLSchema#string

Walter J Storkus

http://www.w3.org/2001/XMLSchema#string

Yi Zhang

http://www.w3.org/2001/XMLSchema#string

Zhaoyang You

http://www.w3.org/2001/XMLSchema#string

P2860

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15

Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

Myeloid-derived suppressor cells as regulators of the immune system

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors

Survival adjustment of mature dendritic cells by IL-15.

Interleukin-15 and its receptor augment dendritic cell vaccination against the neu oncogene through the induction of antibodies partially independent of CD4 help.

P304

e959321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/21624011.2014.959321

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275895176

http://www.w3.org/2001/XMLSchema#string

P698

25941586

http://www.w3.org/2001/XMLSchema#string

P932

4292719

http://www.w3.org/2001/XMLSchema#string